Wuhan Greenovo Biotechnology Co.
Latest round
- Series B
Last raised
- Dec 2016
Total raised
- $6M
Investors
- 4
About Wuhan Greenovo Biotechnology Co.
Established in 2012 and based in Wuhan, China., Ltd. is a biomedical material manufacturer that focuses on hemostasis and wound care. In August 2017, the firm was listed on the National Equities Exchange and Quotations. Its stock code is 871920. The company provides medical care experience for clients such as medical staff, patients, medical research institutions and enterprises. The business of the company includes research and development, production and sales of new biomedical materials. The company's products include military first aid hemostasis, intraoperative hemostasis, wound care, dental hemostasis and home care. The company's products focuses on cardiovascular, anesthesiology and intensive care, general surgery. The company’s revenue is generated by providing biomedical materials.
Who invested in Wuhan Greenovo Biotechnology Co.
4 investors across 2 rounds
See all investors in Wuhan Greenovo Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wuhan Greenovo Biotechnology Co.
Who invested in Wuhan Greenovo Biotechnology Co.?
Wuhan Greenovo Biotechnology Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wuhan Greenovo Biotechnology Co. raised?
Wuhan Greenovo Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Wuhan Greenovo Biotechnology Co. last raise money?
Wuhan Greenovo Biotechnology Co.'s most recent round on record is a Series B, in Dec 2016.
What does Wuhan Greenovo Biotechnology Co. do?
Established in 2012 and based in Wuhan, China.
Where is Wuhan Greenovo Biotechnology Co. headquartered?
Wuhan Greenovo Biotechnology Co. is headquartered in Wuhan, China.
Which VCs invest in companies like Wuhan Greenovo Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Wuhan Greenovo Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Wuhan Greenovo Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.